Latest On Radius Health, Inc (RDUS):
About Radius Health, Inc (RDUS):
Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.
General
- Name Radius Health, Inc
- Symbol RDUS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 310
- Last Split Factor1:2
- Last Split Date2014-04-24
- Fiscal Year EndDecember
- IPO Date2014-06-06
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.radiuspharm.com
Valuation
- Forward PE 66.23
- Price/Sales (Trailing 12 Mt.) 4.52
- Enterprise Value Revenue 5.1
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.85
- Next Year EPS Estimate $0.59
- Next Quarter EPS Estimate -$0.42
- Profit Margin -46%
- Operating Margin -35%
- Return on Assets -25%
- Revenue 238.64 million
- Earnings Per Share -$3.70
- Revenue Per Share $5.14
- Gross Profit 222.24 million
- Quarterly Earnings Growth 12.8%
Highlights
- Market Capitalization 1.03 billion
- EBITDA -146914000
- PE Ratio -1.53
- PEG Ratio -0.16
- Analyst Target Price $23.14
Share Statistics
- Shares Outstanding 46.89 million
- Shares Float 46.76 million
- % Held by Insiders 20%
- % Held by Institutions 105.91%
- Shares Short 5.91 million
- Shares Short Prior Month 5.65 million
- Short Ratio 15.23
- Short % of Float 17%
- Short % of Shares Outstanding 13%
Technicals
- Beta 0.93
- 52 Week High $23.84
- 52 Week Low $10.15
- 50 Day Moving Average 20.55
- 200 Day Moving Average 16.65
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 4.81%
Radius Health, Inc (RDUS) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|---|---|---|---|
2024-07-22 | 2024-08-05 | 2024-07-22 | 2024-07-02 | $0.19 |
2024-04-19 | 2024-05-06 | 2024-04-22 | 2024-04-01 | $0.19 |
2024-02-02 | 2024-02-20 | 2024-02-05 | 2024-01-04 | $0.19 |
2023-11-10 | 2023-11-27 | 2023-11-13 | 2023-10-25 | $0.19 |
Radius Health, Inc (RDUS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $62.78 million | -$0.23 | -$0.14 | -60.84% |
2020-09-30 | 2020-11-05 | $77.83 million | $0.15 | -$0.05 | 383.55% |
2020-06-30 | 2020-08-10 | $N/A | -$0.67 | -$0.51 | -31.37% |
2020-03-31 | 2020-05-07 | $N/A | -$0.59 | -$0.54 | -8.6% |
2019-12-31 | 2020-02-27 | $55.67 million | -$0.29 | -$0.49 | 40.51% |
2019-09-30 | 2019-11-05 | $46.77 million | -$0.65 | -$0.73 | 10.96% |
2019-06-30 | 2019-08-07 | $41.04 million | -$0.77 | -$0.76 | -1.67% |
2019-03-31 | 2019-05-08 | $29.84 million | -$0.94 | -$0.82 | -14.63% |
2018-12-31 | 2019-02-28 | $34.42 million | -$0.81 | -$1.12 | 27.08% |
2018-09-30 | 2018-11-01 | $27.64 million | -$1.00 | -$1.28 | 21.92% |
2018-06-30 | 2018-08-07 | $22.63 million | -$1.18 | -$1.34 | 12.16% |
2018-03-31 | 2018-05-10 | $14.55 million | -$1.37 | -$1.46 | 5.93% |
2017-12-31 | 2018-03-01 | $7.66 million | -$1.59 | -$1.43 | -10.94% |
2017-09-30 | 2017-11-02 | $13.47 million | -$1.31 | -$1.28 | -2.08% |
2017-06-30 | 2017-08-03 | $980000 | -$1.58 | -$1.23 | -28.32% |
2017-03-31 | 2017-05-01 | $N/A | -$1.32 | -$1.18 | -11.63% |
2016-12-31 | 2017-02-23 | $N/A | -$1.22 | -$1.31 | 6.95% |
2016-09-30 | 2016-11-03 | $N/A | -$1.07 | -$1.07 | 0% |
2016-06-30 | 2016-08-04 | $N/A | -$1.01 | -$1.00 | -1.44% |
2016-03-31 | 2016-05-05 | $N/A | -$0.94 | -$0.75 | -25% |
2015-12-31 | 2016-02-25 | $N/A | -$0.77 | -$0.63 | -22.22% |
2015-09-30 | 2015-11-05 | $N/A | -$0.68 | -$0.57 | -19.3% |
2015-06-30 | 2015-08-06 | $N/A | -$0.61 | -$0.52 | -17.31% |
2015-03-31 | 2015-05-06 | $N/A | -$0.47 | -$0.52 | 9.62% |
2014-12-31 | 2015-03-10 | $N/A | -$0.55 | -$0.63 | 12.7% |
2014-09-30 | 2014-11-10 | $N/A | -$0.59 | -$0.65 | 9.23% |
2014-06-30 | 2014-08-12 | $N/A | -$2.19 | -$0.89 | -146.07% |
Radius Health, Inc (RDUS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Radius Health, Inc (RDUS) Chart:
Radius Health, Inc (RDUS) News:
Below you will find a list of latest news for Radius Health, Inc (RDUS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Radius Health, Inc (RDUS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2025-02-21 | 2.5 | 12.57 | CALL | 0 | 2.05 | TRUE | 12.57 | 0 | |
2025-02-21 | 12.5 | 5.87 | CALL | 1 | 0.5 | TRUE | 5.87 | 0 | |
2025-02-21 | 15 | 2.38 | CALL | 1 | 1 | 0.55 | TRUE | 2.75 | 0 |
2025-02-21 | 17.5 | 3.5 | CALL | 1 | 1 | 0.56 | TRUE | 0.4 | 12.9 |
2025-02-21 | 20 | 2.1 | CALL | 15 | 17 | 0.52 | FALSE | 1.05 | 0 |
2025-02-21 | 22.5 | 1.15 | CALL | 23 | 57 | 0.53 | FALSE | 0.7 | 0 |
2025-02-21 | 25 | 0.75 | CALL | 9 | 31 | 0.53 | FALSE | 0.75 | 0 |
2025-02-21 | 30 | 0.15 | CALL | 12 | 12 | 0.98 | FALSE | 0 | 0 |
2025-02-21 | 7.5 | 0.3 | PUT | 133 | 133 | 0.74 | FALSE | 0.3 | 0 |
2025-02-21 | 10 | 0.75 | PUT | 100 | 143 | 0.64 | FALSE | 0.8 | 0 |
2025-02-21 | 12.5 | 0.92 | PUT | 2 | 3 | 0.61 | FALSE | 1.95 | 0 |
2025-02-21 | 15 | 3.5 | PUT | 5 | 1 | 0.56 | FALSE | 3.5 | 0 |
2025-02-21 | 17.5 | 5.27 | PUT | 1 | 1 | 0.54 | FALSE | 5.27 | 0 |
2025-02-21 | 20 | 5.6 | PUT | 29 | 52 | 0.62 | TRUE | 5.6 | 0 |
2025-02-21 | 22.5 | 6 | PUT | 7 | 17 | 0.91 | TRUE | 0 | 0 |
2025-02-21 | 25 | 8.2 | PUT | 5 | 0.54 | TRUE | 8.2 | 0 | |
2025-05-16 | 20 | 1.8 | CALL | 3 | 0.55 | FALSE | 1.8 | 0 | |
2025-05-16 | 22.5 | 1.15 | CALL | 7 | 0.61 | FALSE | 1.15 | 0 | |
2025-05-16 | 25 | 1.47 | CALL | 1 | 15 | 0.55 | FALSE | 1.47 | 0 |
2025-05-16 | 17.5 | 2.45 | PUT | 10 | 20 | 0.56 | FALSE | 2.45 | 0 |
2025-05-16 | 20 | 4.2 | PUT | 3 | 3 | 0.58 | TRUE | 4.2 | 0 |
Latest RDUS Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 2 | $6.855 |
Jun 13, 2022 7:59 PM EST | 1 | $6.86 |
Jun 13, 2022 7:59 PM EST | 100 | $6.86 |
Jun 13, 2022 7:59 PM EST | 1 | $6.86 |
Jun 13, 2022 7:59 PM EST | 200 | $6.86 |
Radius Health, Inc (RDUS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520175726/0001193125-20-175726-index.htm |
2018-08-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000008025518002797/0000080255-18-002797-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000008025519002673/0000080255-19-002673-index.htm |
2019-11-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000008025519002992/0000080255-19-002992-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000008025520001270/0000080255-20-001270-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000009375119000103/0000093751-19-000103-index.htm |
2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000009375120000409/0000093751-20-000409-index.htm |
2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000021545719005790/0000215457-19-005790-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000031506619001301/0000315066-19-001301-index.htm |
2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000083423720006873/0000834237-20-006873-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000089914019000218/0000899140-19-000218-index.htm |
2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924318022027/0000899243-18-022027-index.htm |
2018-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924318022543/0000899243-18-022543-index.htm |
2018-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924318022966/0000899243-18-022966-index.htm |
2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924318031191/0000899243-18-031191-index.htm |
2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924318031549/0000899243-18-031549-index.htm |
2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924319003965/0000899243-19-003965-index.htm |
2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924319026963/0000899243-19-026963-index.htm |
2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924320011906/0000899243-20-011906-index.htm |
2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924320018807/0000899243-20-018807-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924320024980/0000899243-20-024980-index.htm |
2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000089924320025283/0000899243-20-025283-index.htm |
2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000090221919000365/0000902219-19-000365-index.htm |
2020-01-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000090221920000049/0000902219-20-000049-index.htm |
2020-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000090221920000369/0000902219-20-000369-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000093247119005993/0000932471-19-005993-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000108514619000744/0001085146-19-000744-index.htm |
2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000110465920017825/0001104659-20-017825-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000110465920020755/0001104659-20-020755-index.htm |
2018-08-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000114420418045140/0001144204-18-045140-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000114420419007537/0001144204-19-007537-index.htm |
2018-08-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1428522/000119312518246182/0001193125-18-246182-index.htm |
2018-08-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1428522/000119312518263607/0001193125-18-263607-index.htm |
2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520123248/0001193125-20-123248-index.htm |
2020-05-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1428522/000119312520145785/0001193125-20-145785-index.htm |
2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520175726/0001193125-20-175726-index.htm |
2020-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520197805/0001193125-20-197805-index.htm |
2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520214137/0001193125-20-214137-index.htm |
2020-09-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520238156/0001193125-20-238156-index.htm |
2020-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520252861/0001193125-20-252861-index.htm |
2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000119312520286265/0001193125-20-286265-index.htm |
2018-09-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919118049621/0001209191-18-049621-index.htm |
2018-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919118049624/0001209191-18-049624-index.htm |
2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919118063053/0001209191-18-063053-index.htm |
2019-01-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119005311/0001209191-19-005311-index.htm |
2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119005314/0001209191-19-005314-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009729/0001209191-19-009729-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009734/0001209191-19-009734-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009739/0001209191-19-009739-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009745/0001209191-19-009745-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009753/0001209191-19-009753-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009760/0001209191-19-009760-index.htm |
2019-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009775/0001209191-19-009775-index.htm |
2019-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009779/0001209191-19-009779-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009783/0001209191-19-009783-index.htm |
2019-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009789/0001209191-19-009789-index.htm |
2019-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009800/0001209191-19-009800-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013698/0001209191-19-013698-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013699/0001209191-19-013699-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013701/0001209191-19-013701-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013704/0001209191-19-013704-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013706/0001209191-19-013706-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013710/0001209191-19-013710-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013712/0001209191-19-013712-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013715/0001209191-19-013715-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013718/0001209191-19-013718-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013720/0001209191-19-013720-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013722/0001209191-19-013722-index.htm |
2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013735/0001209191-19-013735-index.htm |
2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119017351/0001209191-19-017351-index.htm |
2019-04-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119024476/0001209191-19-024476-index.htm |
2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119025249/0001209191-19-025249-index.htm |
2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119025252/0001209191-19-025252-index.htm |
2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119025254/0001209191-19-025254-index.htm |
2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119029406/0001209191-19-029406-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119036015/0001209191-19-036015-index.htm |
2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919119041027/0001209191-19-041027-index.htm |
2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120009592/0001209191-20-009592-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012138/0001209191-20-012138-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012139/0001209191-20-012139-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012144/0001209191-20-012144-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012146/0001209191-20-012146-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012148/0001209191-20-012148-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012151/0001209191-20-012151-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012152/0001209191-20-012152-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012153/0001209191-20-012153-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012155/0001209191-20-012155-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012156/0001209191-20-012156-index.htm |
2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012186/0001209191-20-012186-index.htm |
2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013789/0001209191-20-013789-index.htm |
2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013790/0001209191-20-013790-index.htm |
2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013792/0001209191-20-013792-index.htm |
2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013793/0001209191-20-013793-index.htm |
2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013794/0001209191-20-013794-index.htm |
2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013795/0001209191-20-013795-index.htm |
2020-04-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120026150/0001209191-20-026150-index.htm |
2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120026151/0001209191-20-026151-index.htm |
2020-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120046368/0001209191-20-046368-index.htm |
2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120046375/0001209191-20-046375-index.htm |
2020-10-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1428522/000120919120054092/0001209191-20-054092-index.htm |
2018-08-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1428522/000121465918005605/0001214659-18-005605-index.htm |
2018-09-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000131924418000054/0001319244-18-000054-index.htm |
2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000131924419000021/0001319244-19-000021-index.htm |
2019-06-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000131924419000052/0001319244-19-000052-index.htm |
2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1428522/000131924420000041/0001319244-20-000041-index.htm |
2018-09-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459018023377/0001564590-18-023377-index.htm |
2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459018025998/0001564590-18-025998-index.htm |
2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019000301/0001564590-19-000301-index.htm |
2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019001104/0001564590-19-001104-index.htm |
2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019005448/0001564590-19-005448-index.htm |
2019-04-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1428522/000156459019011988/0001564590-19-011988-index.htm |
2019-04-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1428522/000156459019011990/0001564590-19-011990-index.htm |
2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019014392/0001564590-19-014392-index.htm |
2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019016831/0001564590-19-016831-index.htm |
2019-05-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1428522/000156459019018024/0001564590-19-018024-index.htm |
2019-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019022047/0001564590-19-022047-index.htm |
2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019030042/0001564590-19-030042-index.htm |
2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019040372/0001564590-19-040372-index.htm |
2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459019046550/0001564590-19-046550-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459020000925/0001564590-20-000925-index.htm |
2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459020007025/0001564590-20-007025-index.htm |
2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459020011890/0001564590-20-011890-index.htm |
2020-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459020012999/0001564590-20-012999-index.htm |
2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459020013701/0001564590-20-013701-index.htm |
2020-04-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1428522/000156459020017261/0001564590-20-017261-index.htm |
2020-04-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1428522/000156459020017268/0001564590-20-017268-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459020022889/0001564590-20-022889-index.htm |
2020-05-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1428522/000156459020023562/0001564590-20-023562-index.htm |
2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1428522/000156459020028620/0001564590-20-028620-index.htm |
2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828018010589/0001628280-18-010589-index.htm |
2018-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828018013236/0001628280-18-013236-index.htm |
2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1428522/000162828019002275/0001628280-19-002275-index.htm |
2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828019006186/0001628280-19-006186-index.htm |
2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828019010286/0001628280-19-010286-index.htm |
2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828019013328/0001628280-19-013328-index.htm |
2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1428522/000162828020002354/0001628280-20-002354-index.htm |
2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828020006972/0001628280-20-006972-index.htm |
2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828020012243/0001628280-20-012243-index.htm |
2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1428522/000162828020015691/0001628280-20-015691-index.htm |
2018-08-23 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1428522/999999999718007434/9999999997-18-007434-index.htm |
2020-05-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1428522/999999999720003006/9999999997-20-003006-index.htm |
Radius Health, Inc (RDUS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Radius Health, Inc (RDUS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 20%Institutional Ownership: 10591%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-02-22 | Anthony Rosenberg | Director | Buy | 5,500.00 | 10,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013720/0001209191-19-013720-index.htm | ||
2019-02-22 | CATHY FRIEDMAN | Director | Buy | 5,500.00 | 10,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013699/0001209191-19-013699-index.htm | ||
2019-02-22 | Debasish Roychowdhury | Director | Buy | 5,500.00 | 10,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013722/0001209191-19-013722-index.htm | ||
2019-02-22 | JEAN PIERRE GARNIER | Director | Buy | 5,500.00 | 10,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013701/0001209191-19-013701-index.htm | ||
2019-02-22 | Kurt Graves | Director | Buy | 5,500.00 | 10,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013704/0001209191-19-013704-index.htm | ||
2019-02-22 | Owen Hughes | Director | Buy | 5,500.00 | 10,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013712/0001209191-19-013712-index.htm | ||
2019-02-22 | Willard H Dere | Director | Buy | 5,500.00 | 10,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013698/0001209191-19-013698-index.htm | ||
2020-02-26 | Owen Hughes | Director | Sell | 2,750.00 | 17.95 | 49,362.50 | 10,650.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013795/0001209191-20-013795-index.htm |
2020-02-20 | Kurt Graves | Director | Buy | 5,500.00 | 11,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012146/0001209191-20-012146-index.htm | ||
2020-02-26 | Willard H Dere | Director | Sell | 1,925.00 | 17.95 | 34,553.75 | 12,195.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013790/0001209191-20-013790-index.htm |
2020-02-26 | Anthony Rosenberg | Director | Sell | 1,815.00 | 17.95 | 32,579.25 | 12,401.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013792/0001209191-20-013792-index.htm |
2019-03-05 | Jessica Hopfield | Director | Buy | 12,800.00 | 19.23 | 246,190.08 | 12,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119017351/0001209191-19-017351-index.htm |
2019-02-22 | Joseph Francis Kelly | Sr. VP of Sales and Marketing | Buy | 10,000.00 | 13,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013715/0001209191-19-013715-index.htm | ||
2020-02-20 | Owen Hughes | Director | Buy | 5,500.00 | 13,400.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012152/0001209191-20-012152-index.htm | ||
2020-02-20 | Willard H Dere | Director | Buy | 5,500.00 | 14,120.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012139/0001209191-20-012139-index.htm | ||
2020-02-20 | Anthony Rosenberg | Director | Buy | 5,500.00 | 14,216.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012156/0001209191-20-012156-index.htm | ||
2019-02-22 | Charles Q Morris | Chief Medical Officer | Buy | 15,000.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013718/0001209191-19-013718-index.htm | ||
2020-02-20 | CATHY FRIEDMAN | Director | Buy | 5,500.00 | 15,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012186/0001209191-20-012186-index.htm | ||
2020-02-20 | JEAN PIERRE GARNIER | Director | Buy | 5,500.00 | 15,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012144/0001209191-20-012144-index.htm | ||
2019-02-22 | Brent Hatzis-Schoch | Sr. VP, General Counsel | Buy | 15,000.00 | 17,944.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013706/0001209191-19-013706-index.htm | ||
2019-02-22 | Jose Carmona | Chief Financial Officer | Buy | 15,000.00 | 18,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119013735/0001209191-19-013735-index.htm | ||
2020-02-20 | Jessica Hopfield | Director | Buy | 5,500.00 | 18,300.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012151/0001209191-20-012151-index.htm | ||
2020-02-26 | Joseph Francis Kelly | Sr. VP of Sales and Marketing | Sell | 889.00 | 17.93 | 15,942.44 | 24,111.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013794/0001209191-20-013794-index.htm |
2020-02-20 | Joseph Francis Kelly | Sr. VP of Sales and Marketing | Buy | 17,500.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012153/0001209191-20-012153-index.htm | ||
2018-12-17 | Joseph Francis Kelly | Sr. VP of Sales and Marketing | Buy | 3,000.00 | 15.71 | 47,130.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919118063053/0001209191-18-063053-index.htm |
2020-02-26 | Charles Q Morris | Chief Medical Officer | Sell | 1,256.00 | 17.93 | 22,523.85 | 33,744.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013793/0001209191-20-013793-index.htm |
2020-02-20 | Charles Q Morris | Chief Medical Officer | Buy | 20,000.00 | 35,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012155/0001209191-20-012155-index.htm | ||
2020-02-26 | Jose Carmona | Chief Financial Officer | Sell | 1,292.00 | 17.93 | 23,169.44 | 46,708.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120013789/0001209191-20-013789-index.htm |
2019-02-13 | Anthony Rosenberg | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009760/0001209191-19-009760-index.htm | ||
2019-02-13 | CATHY FRIEDMAN | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009734/0001209191-19-009734-index.htm | ||
2019-02-13 | Debasish Roychowdhury | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009783/0001209191-19-009783-index.htm | ||
2019-02-13 | JEAN PIERRE GARNIER | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009739/0001209191-19-009739-index.htm | ||
2019-02-13 | Kurt Graves | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009745/0001209191-19-009745-index.htm | ||
2019-02-13 | Owen Hughes | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009753/0001209191-19-009753-index.htm | ||
2019-02-13 | Willard H Dere | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119009729/0001209191-19-009729-index.htm | ||
2020-02-20 | Jose Carmona | Chief Financial Officer | Buy | 30,000.00 | 48,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919120012138/0001209191-20-012138-index.htm | ||
2019-05-10 | Joseph Francis Kelly | Sr. VP of Sales and Marketing | Buy | 2,000.00 | 21.43 | 42,860.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119029406/0001209191-19-029406-index.htm |
2019-04-11 | Debasish Roychowdhury | Director | Sell | 4,800.00 | 22.15 | 106,320.00 | 5,500.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119024476/0001209191-19-024476-index.htm |
2019-04-16 | Kurt Graves | Director | Sell | 4,800.00 | 22.32 | 107,136.00 | 5,500.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119025252/0001209191-19-025252-index.htm |
2018-08-08 | GROWTH N V BIOTECH | 10% Share Holder | Buy | 60,000.00 | 22.73 | 1,363,884.00 | 6,360,913.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924318022027/0000899243-18-022027-index.htm |
2018-08-14 | GROWTH N V BIOTECH | 10% Share Holder | Buy | 100,000.00 | 20.87 | 2,086,880.00 | 6,460,913.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924318022543/0000899243-18-022543-index.htm |
2018-08-15 | GROWTH N V BIOTECH | 10% Share Holder | Buy | 69,363.00 | 20.78 | 1,441,529.61 | 6,530,276.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924318022543/0000899243-18-022543-index.htm |
2018-08-20 | GROWTH N V BIOTECH | 10% Share Holder | Buy | 60,000.00 | 19.65 | 1,178,808.00 | 6,590,276.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924318022966/0000899243-18-022966-index.htm |
2018-12-14 | GROWTH N V BIOTECH | 10% Share Holder | Buy | 60,000.00 | 15.64 | 938,256.00 | 6,650,276.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924318031191/0000899243-18-031191-index.htm |
2018-12-20 | GROWTH N V BIOTECH | 10% Share Holder | Buy | 60,000.00 | 14.48 | 868,782.00 | 6,710,276.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924318031549/0000899243-18-031549-index.htm |
2019-11-06 | GROWTH N V BIOTECH | 10% Share Holder | Buy | 100,000.00 | 23.00 | 2,300,300.00 | 6,881,685.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924319026963/0000899243-19-026963-index.htm |
2020-04-30 | TARGET N V BIOTECH | 10% Share Holder | Buy | 50,000.00 | 15.75 | 787,555.00 | 6,931,685.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924320011906/0000899243-20-011906-index.htm |
2020-07-08 | TARGET N V BIOTECH | 10% Share Holder | Buy | 25,000.00 | 13.21 | 330,177.50 | 6,956,685.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924320018807/0000899243-20-018807-index.htm |
2020-09-11 | TARGET N V BIOTECH | 10% Share Holder | Buy | 199,029.00 | 11.33 | 2,255,117.99 | 7,155,714.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924320024980/0000899243-20-024980-index.htm |
2020-09-14 | TARGET N V BIOTECH | 10% Share Holder | Buy | 200,000.00 | 11.69 | 2,338,680.00 | 7,355,714.00 | https://www.sec.gov/Archives/edgar/data/1428522/000089924320025283/0000899243-20-025283-index.htm |
2019-06-07 | Joseph Francis Kelly | Sr. VP of Sales and Marketing | Buy | 2,500.00 | 21.81 | 54,536.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119036015/0001209191-19-036015-index.htm |
2019-04-16 | Owen Hughes | Director | Sell | 2,400.00 | 22.22 | 53,328.00 | 7,900.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119025254/0001209191-19-025254-index.htm |
2019-04-16 | Willard H Dere | Director | Sell | 1,680.00 | 22.22 | 37,329.60 | 8,620.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119025249/0001209191-19-025249-index.htm |
2019-07-01 | Anthony Rosenberg | Director | Sell | 1,584.00 | 24.60 | 38,966.40 | 8,716.00 | https://www.sec.gov/Archives/edgar/data/1428522/000120919119041027/0001209191-19-041027-index.htm |